Hedge Funds Think Colgate-Palmolive Is One of the Best Dividend King Stocks To Buy
π Colgate-Palmolive has increased its dividend for 63 consecutive years, earning its status as a 'Dividend King' with an uninterrupted payment history dating back to 1895.
π¦· The company maintains a dominant 41.3% market share in the toothpaste sector and holds a significant position in the manual toothbrush market.
πΎ Hill's Science Diet is a key growth asset within the Pet Nutrition segment, catering to pet owners willing to pay premium prices for health-focused nutrition.
π° In September 2026, the company declared a quarterly dividend of $0.53 per share, providing an annual yield of approximately 2.5% at a stock price of $86.
π Operating cash flow reached $1.742 billion in the first six months of 2026, demonstrating sufficient liquidity to support regular dividend payments and business reinvestment.
βοΈ The earnings payout ratio is currently around 84%, meaning a large portion of reported profits are paid out as dividends rather than retained for expansion.
π Colgate-Palmolive trades at a forward P/E multiple of approximately 21x, reflecting a premium valuation for its mature consumer goods business and stable cash flows.
π Hedge funds rank CL among the top 10 'Dividend King' stocks, though it trails nine other companies on the specific list mentioned in the analysis.
π Compared to Procter & Gamble (PG), Colgate is viewed as a cheaper investment with similar forward P/E multiples but expected faster earnings growth.
β οΈ The high valuation implies an earnings yield of about 4.8%, which may be less attractive than government bonds if interest rates remain elevated or stable.
- Colgate-Palmolive has a proven track record of increasing dividends for 63 consecutive years, establishing it as a reliable 'Dividend King' with an uninterrupted payment history since 1895.
- The company holds a dominant 41.3% market share in the toothpaste market and maintains strong brand recognition that creates high barriers to entry for competitors.
- Hill's Science Diet is a highly profitable asset within the Pet Nutrition segment, benefiting from consumers' willingness to pay premium prices for veterinary-recommended pet food.
- Operating cash flow of $1.742 billion in the first half of 2026 provides management with ample scope to sustain dividend payments and fund business reinvestment initiatives.
- Hedge funds consider CL one of the top 10 'Dividend King' stocks, validating its status as a premier defensive investment for long-term portfolios.
- The stock trades at a premium valuation with a forward P/E of approximately 21x, leaving little room for earnings to decline without significantly impacting the share price.
- With a forward P/E of 21x and an implied earnings yield of 4.8%, the stock may be less attractive than government bonds for investors seeking competitive returns in a stable rate environment.
- The current dividend yield of approximately 2.5% is considered conservative and insufficient for investors requiring substantial immediate income compared to higher-yielding alternatives.